Large and small artery endothelial function in patients with essential hypertension – Effect of ACE inhibition and beta‐blockade

References

• Lewington S., Clarke R., Qizilbash N., Peto R., Collins R. Age‐specific relevance of usual blood pressure to vascular mortality: A meta‐analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903–1913
   PubMed Web of Science ®Google Scholar
• Celermajer D. S., Sorensen K. E., Gooch V. M., Spiegelhalter D. J., Miller O. I., Sullivan I. D., et al. Non‐invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111–1115
   PubMed Web of Science ®Google Scholar
• Halcox J. P., Schenke W. H., Zalos G., Mincemoyer R., Prasad A., Waclawiw M. A., et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002; 106: 653–658
   PubMed Web of Science ®Google Scholar
• Laurent S., Lacolley P., Brunel P., Laloux B., Pannier B., Safar M. Flow‐dependent vasodilation of brachial artery in essential hypertension. Am J Physiol 1990; 258: H1004–H1011
   PubMedGoogle Scholar
• Mitchell G. F., Parise H., Vita J. A., Larson M. G., Warner E., Keaney J. F, Jr., et al. Local shear stress and brachial artery flow‐mediated dilation: The Framingham Heart Study. Hypertension 2004; 44: 134–139
   PubMed Web of Science ®Google Scholar
• Levenson J., Pessana F., Gariepy J., Armentano R., Simon A. Gender differences in wall shear‐mediated brachial artery vasoconstriction and vasodilation. J Am Coll Cardiol 2001; 38: 1668–1674
   PubMed Web of Science ®Google Scholar
• Betik A. C., Luckham V. B., Hughson R. L. Flow‐mediated dilation in human brachial artery after different circulatory occlusion conditions. Am J Physiol 2004; 286: H442–H448
   Web of Science ®Google Scholar
• Celermajer D. S., Sorensen K. E., Bull C., Robinson J., Deanfield J. E. Endothelium‐dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994; 24: 1468–1474
   PubMed Web of Science ®Google Scholar
• Gnasso A., Carallo C., Irace C., De Franceschi M. S., Mattioli P. L., Motti C., et al. Association between wall shear stress and flow‐mediated vasodilation in healthy men. Atherosclerosis 2001; 156: 171–176
   PubMed Web of Science ®Google Scholar
• Pyke K. E., Dwyer E. M., Tschakovsky M. E. Impact of controlling shear rate on flow‐mediated dilation responses in the brachial artery of humans. J Appl Physiol 2004; 97: 499–508
   PubMed Web of Science ®Google Scholar
• Buus N. H., Bottcher M., Jorgensen C. G., Christensen K. L., Thygesen K., Nielsen T. T., et al. Myocardial perfusion during long‐term angiotensin‐converting enzyme inhibition or beta‐blockade in patients with essential hypertension. Hypertension 2004; 44: 465–470
   PubMed Web of Science ®Google Scholar
• Sorensen K. E., Celermajer D. S., Spiegelhalter D. J., Georgakopoulos D., Robinson J., Thomas O., et al. Non‐invasive measurement of human endothelium dependent arterial responses: Accuracy and reproducibility. Br Heart J 1995; 74: 247–253
   PubMedGoogle Scholar
• Buus N. H., Bottcher M., Bottker H. E., Sorensen K. E., Nielsen T. T., Mulvany M. J. Reduced vasodilator capacity in syndrome X related to structure and function of resistance arteries. Am J Cardiol 1999; 83: 149–154
   PubMed Web of Science ®Google Scholar
• Sorensen K. E., Dorup I., Hermann A. P., Mosekilde L. Combined hormone replacement therapy does not protect women against the age‐related decline in endothelium‐dependent vasomotor function. Circulation 1998; 97: 1234–1238
   PubMed Web of Science ®Google Scholar
• Thybo N. K., Stephens N., Cooper A., Aalkjaer C., Heagerty A. M., Mulvany M. J. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 1995; 25: 474–481
   PubMed Web of Science ®Google Scholar
• Joannides R., Haefeli W. E., Linder L., Richard V., Bakkali E. H., Thuillez C., et al. Nitric oxide is responsible for flow‐dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995; 91: 1314–1319
   PubMed Web of Science ®Google Scholar
• Doshi S. N., Naka K. K., Payne N., Jones C. J., Ashton M., Lewis M. J., et al. Flow‐mediated dilatation following wrist and upper arm occlusion in humans: The contribution of nitric oxide. Clin Sci (Lond) 2001; 101: 629–635
   PubMed Web of Science ®Google Scholar
• Thorsgaard M., Lopez V., Buus N. H., Simonsen U. Different modulation by Ca2+‐activated K+ channel blockers and herbimycin of acetylcholine‐ and flow‐evoked vasodilatation in rat mesenteric small arteries. Br J Pharmacol 2003; 138: 1562–1570
   PubMed Web of Science ®Google Scholar
• Paniagua O. A., Bryant M. B., Panza J. A. Role of endothelial nitric oxide in shear stress‐induced vasodilation of human microvasculature: Diminished activity in hypertensive and hypercholesterolemic patients. Circulation 2001; 103: 1752–1758
   PubMed Web of Science ®Google Scholar
• Muiesan M. L., Salvetti M., Monteduro C., Corbellini C., Guelfi D., Rizzoni D., et al. Flow‐mediated dilatation of the brachial artery and left ventricular geometry in hypertensive patients. J Hypertens 2001; 19: 641–647
   PubMed Web of Science ®Google Scholar
• Olsen M. H., Wachtell K., Hermann K. L., Bella J. N., Dige‐Petersen H., Rokkedal J., et al. Left ventricular hypertrophy is associated with reduced vasodilatory capacity in the brachial artery in patients with longstanding hypertension. A LIFE substudy. Blood Press 2002; 11: 285–292
   PubMed Web of Science ®Google Scholar
• Ghiadoni L., Magagna A., Versari D., Kardasz I., Huang Y., Taddei S., et al. Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension 2003; 41: 1281–1286
   PubMed Web of Science ®Google Scholar
• Lauer T., Hei C., Preik M., Balzer J., Hafner D., Strauer B. E., et al. Reduction of peripheral flow reserve impairs endothelial function in conduit arteries of patients with essential hypertension. J Hypertens 2005; 23: 563–569
   PubMed Web of Science ®Google Scholar
• Muiesan M. L., Salvetti M., Monteduro C., Rizzoni D., Zulli R., Corbellini C., et al. Effect of treatment on flow‐dependent vasodilation of the brachial artery in essential hypertension. Hypertension 1999; 33: 575–580
   PubMed Web of Science ®Google Scholar
• Komai N., Ohishi M., Morishita R., Moriguchi A., Kaibe M., Matsumoto K., et al. Serum hepatocyte growth factor concentration is correlated with the forearm vasodilator response in hypertensive patients. Am J Hypertens 2002; 15: 499–506
   PubMed Web of Science ®Google Scholar
• Munakata M., Aihara A., Nunokawa T., Ito N., Imai Y., Ito S., et al. The influence of one‐year treatment by angiotensin converting enzyme inhibitor on baroreflex sensitivity and flow‐mediated vasodilation of the brachial artery in essential hypertension – Comparison with calcium channel blockers. Clin Exp Hypertens 2003; 25: 169–181
   PubMed Web of Science ®Google Scholar
• Chung N. A., Beevers D. G., Lip G. Effects of losartan versus hydrochlorothiazide on indices of endothelial damage/dysfunction, angiogenesis and tissue factor in essential hypertension. Blood Press 2004; 13: 183–189
   PubMed Web of Science ®Google Scholar
• Hornig B., Landmesser U., Kohler C., Ahlersmann D., Spiekermann S., Christoph A., et al. Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: Role of superoxide dismutase. Circulation 2001; 103: 799–805
   PubMed Web of Science ®Google Scholar
• Taddei S., Virdis A., Ghiadoni L., Magagna A., Pasini A. F., Garbin U., et al. Effect of calcium antagonist or beta blockade treatment on nitric oxide‐dependent vasodilation and oxidative stress in essential hypertensive patients. J Hypertens 2001; 19: 1379–1386
   PubMed Web of Science ®Google Scholar
• Baykal Y., Yilmaz M. I., Celik T., Gok F., Rehber H., Akay C., et al. Effects of antihypertensive agents, alpha receptor blockers, beta blockers, angiotensin‐converting enzyme inhibitors, angiotensin receptor blockers and calcium channel blockers, on oxidative stress. J Hypertens 2003; 21: 1207–1211
   PubMed Web of Science ®Google Scholar
• Buus N. H., Simonsen U., Pilegaard H. K., Mulvany M. J. Nitric oxide, prostanoid and non‐NO, non‐prostanoid involvement in acetylcholine relaxation of isolated human small arteries. Br J Pharmacol 2000; 129: 184–192
   PubMed Web of Science ®Google Scholar
• Panza J. A., Quyyumi A. A., Brush J. E, Jr., Epstein S. E. Abnormal endothelium‐dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22–27
   PubMed Web of Science ®Google Scholar
• Rossi M., Taddei S., Fabbri A., Tintori G., Credidio L., Virdis A., et al. Cutaneous vasodilation to acetylcholine in patients with essential hypertension. J Cardiovasc Pharmacol 1997; 29: 406–411
   PubMed Web of Science ®Google Scholar
• Cockcroft J. R., Chowienczyk P. J., Benjamin N., Ritter J. M. Preserved endothelium‐dependent vasodilatation in patients with essential hypertension. N Engl J Med 1994; 330: 1036–1040
   PubMed Web of Science ®Google Scholar
• Schiffrin E. L., Deng L. Y. Structure and function of resistance arteries of hypertensive patients treated with a beta‐blocker or a calcium channel antagonist. J Hypertens 1996; 14: 1247–1255
   PubMed Web of Science ®Google Scholar
• Rizzoni D., Muiesan M. L., Porteri E., Castellano M., Zulli R., Bettoni G., et al. Effects of long‐term antihypertensive treatment with lisinopril on resistance arteries in hypertensive patients with left ventricular hypertrophy. J Hypertens 1997; 15: 197–204
   PubMed Web of Science ®Google Scholar
• Christensen F. H., Hansen T., Stankevicius E., Buus N. H., Simonsen U. Elevated pressure selectively blunts flow‐evoked vasodilatation in rat mesenteric small arteries. Br J Pharmacol 2007; 150: 80–87
   PubMed Web of Science ®Google Scholar
• Schiffrin E. L., Deng L. Y., Larochelle P. Effects of a beta‐blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension 1994; 23: 83–91
   PubMed Web of Science ®Google Scholar
• Thybo N. K., Mulvany M. J., Jastrup B., Nielsen H., Aalkjaer C. Some pharmacological and elastic characteristics of isolated subcutaneous small arteries from patients with essential hypertension. J Hypertens 1996; 14: 993–998
   PubMed Web of Science ®Google Scholar
• Schiffrin E. L., Park J. B., Pu Q. Effect of crossing over hypertensive patients from a beta‐blocker to an angiotensin receptor antagonist on resistance artery structure and on endothelial function. J Hypertens 2002; 20: 71–78
   PubMed Web of Science ®Google Scholar